French Society of Ophthalmology (SFO ) Guidelines for the follow-up of paediatric patients during the Covid-19 epidemic

French Society of Ophthalmology (SFO ) Guidelines for the follow-up of paediatric patients during the Covid-19 epidemic
Colin Kerr
Colin Kerr
Published: Tuesday, April 21, 2020
The French Society of Ophthalmology (SFO) have drawn up  Guidelines for the follow-up of paediatric patients during the Covid-19 epidemic. The guidelines were written by Prof. J Claude Speeg-Schatz, University Hospital Strasbourg, France Which cases should be seen and which cases postponed? In cases of amblyopia:  If the child is already being monitored, we continue the treatment and postpone the appointment. Follow-up of ametropia can be postponed.  If the child is not being monitored and has a decrease in visual acuity or strabismus: under six years of age the patient should be seen to eliminate an organic cause (fundus examination). Retinoscopy may be deferred to a later date. In cases of strabismus, alternate or unilateral occlusion therapy can be performed according to the case. In cases of sudden onset strabismus or recent nystagmus: children under two years-of-age are to be seen urgently to eliminate an organic cause (retinoblastoma, tumours...): fundus examination. In the event of a suspicious or obvious organic problem: leukocoria, buphthalmos, megalocornea, tearing (except in cases of imperforation of the lacrimal passages), photophobia, the child should be seen in the emergency room. In case of infections (red and/or painful eye, secretions, oedema), and trauma, children should be seen in the emergency room. Source: French Society of Ophthalmology (SFO): https://www.sfo-online.fr/sites/www.sfo-online.fr/files/medias/documents/recommandations_pour_les_consultations_ophtalmopediatrie-covid-19_0.pdf
Tags: covid-19 paediatric
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...